227 related articles for article (PubMed ID: 30887759)
1. Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.
Albert A; Allbright R; Lee A; Vijayakumar S
J Gynecol Oncol; 2019 May; 30(3):e41. PubMed ID: 30887759
[TBL] [Abstract][Full Text] [Related]
2. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.
Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141
[TBL] [Abstract][Full Text] [Related]
4. Utilization of Hysterectomy Following Chemoradiation for IB2/IIA2 Cervical Cancer in the National Cancer Data Base.
Haque W; Verma V; Butler EB; Teh BS
Anticancer Res; 2018 May; 38(5):3175-3179. PubMed ID: 29715159
[TBL] [Abstract][Full Text] [Related]
5. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Survival Rates and Prognostic Factors of Cervix Cancer Treated by Different Modalities.
Viani GA; Dos Santos FM; Pavoni JF
Am J Clin Oncol; 2020 Jan; 43(1):52-57. PubMed ID: 31764019
[TBL] [Abstract][Full Text] [Related]
7. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
8. Utilization of Postoperative Chemoradiotherapy Among Women in the United States With High-risk Cervical Cancer.
Trifiletti DM; Swisher-McClure S; Showalter TN; Cantrell LA; Grover S
Am J Clin Oncol; 2018 May; 41(5):452-457. PubMed ID: 27322699
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
[TBL] [Abstract][Full Text] [Related]
10. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
Ferrandina G; Gambacorta A; Gallotta V; Smaniotto D; Fagotti A; Tagliaferri L; Foti E; Fanfani F; Autorino R; Scambia G; Valentini V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):778-85. PubMed ID: 25585781
[TBL] [Abstract][Full Text] [Related]
12. Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation.
Ager BJ; Torgeson A; Francis SR; Burt LM; Gaffney DK; Cannon DM
Am J Clin Oncol; 2020 Jan; 43(1):35-42. PubMed ID: 31764024
[TBL] [Abstract][Full Text] [Related]
13. Survival benefits with the addition of adjuvant hysterectomy to radiochemotherapy for treatment of stage I-II adenocarcinoma of the uterine cervix.
Huang XB; Zhang WW; Wu SG; Sun JY; He ZY; Zhou J
J Surg Oncol; 2018 Sep; 118(3):574-580. PubMed ID: 30114328
[TBL] [Abstract][Full Text] [Related]
14. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
16. Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
Garg G; Shah JP; Toy EP; Christensen C; Deppe G; Asaad R; Morris RT
Int J Gynecol Cancer; 2011 May; 21(4):711-6. PubMed ID: 21412165
[TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
[TBL] [Abstract][Full Text] [Related]
18. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery.
Miller H; Matsuo K; Roman LD; Yessaian AA; Pham HQ; Hom M; Castaneda A; Pham A; Ragab O; Muderspach L; Ciccone M; Brunette LL
Radiat Oncol; 2021 Jun; 16(1):123. PubMed ID: 34187504
[TBL] [Abstract][Full Text] [Related]
20. The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer.
Chereau E; DE LA Hosseraye C; Ballester M; Monnier L; Rouzier R; Touboul E; Daraï E
Anticancer Res; 2013 Apr; 33(4):1661-6. PubMed ID: 23564812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
